(Q45521062)

14 December 2017

title

Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy (English)

1 reference

14 December 2017

8

1 reference

14 December 2017

G Eelen

1

1 reference

14 December 2017

I Vanden Bempt

2

1 reference

14 December 2017

L Verlinden

3

1 reference

14 December 2017

M Drijkoningen

4

1 reference

14 December 2017

A Smeets

5

1 reference

14 December 2017

P Neven

6

1 reference

14 December 2017

M R Christiaens

7

1 reference

14 December 2017

R Bouillon

9

1 reference

14 December 2017

A Verstuyf

10

1 reference

14 December 2017

language of work or name

English

0 references

publication date

17 March 2008

1 reference

14 December 2017

1 reference

14 December 2017

volume

27

1 reference

14 December 2017

issue

30

1 reference

14 December 2017

page(s)

4233-4241

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.51

14 December 2017

exact match

0 references

cites work

E2F target genes: unraveling the biology

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The Fanconi anaemia/BRCA pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Microarray analysis of 1alpha,25-dihydroxyvitamin D3-treated MC3T3-E1 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Breast tumor copy number aberration phenotypes and genomic instability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Molecular portraits of human breast tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Polygenic susceptibility to breast cancer and implications for prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Cytogenetic toxicity of antitumor platinum compounds in Fanconi's anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The 17q23 amplicon and breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Common markers of proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

A tumor suppressor and oncogene: the WT1 story.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

The BRCT Domain Is a Phospho-Protein Binding Domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.51

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.51

1 reference

Dimensions Publication ID

14 December 2017

1041919069

0 references

1 reference